SCIU Fees and Costs — Global X Scientific Beta US ETF

Data updated: 2020-09-28

The net expense ratio is 0.19%. There are no sales loads or redemption fees. In fiscal 2019 the fund paid $14K in broker commissions, 0.0142% of average net assets, and portfolio turnover was 45%.

SCIU Fees and Expenses

Annual operating expenses and sales charges of SCIU. Prospectus, as of February 29, 2020.

Annual operating expenses
Management fee0.19%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio0.19%
Fee waiver—
Net expense ratio0.19%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

SCIU Costs Over Time

On $10,000 invested in SCIU, assuming 5% a year before costs, total costs come to $130 over 5 years, cutting the return by 0.21% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.19%)$20$63$110
Trading costs (broker commissions)$1$5$8
Lost growth on money paid in costs$0$3$12
Total costs$21$71$130
Value after costs$10,479$11,505$12,633
Impact on return, per year0.21%0.21%0.21%

SCIU Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2019.

  • Explicit cost rate (commissions ÷ average net assets): 0.0142%
  • Total broker commissions: $14K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 45%
  • Securities lending: none during the year

SCIU Agency Brokers

Commissions paid.

BrokerAmountShare
SUSQUEHANNA INVESTMENT GROUP$13K87.54%
BTIG LLC$8766.05%
CITIGROUP GLOBAL MARKETS$4943.41%
CANTOR FITZGERALD CO$3692.55%
MERRILL LYNCH$650.45%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.